Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection (original) (raw)

References

• Akaike, A. (2006). Preclinical evidence of neuroprotection by cholinesterase inhibitors. Alzheimer Disease and Associated Disorders, 20, S8–S11.
  Article CAS PubMed Google Scholar
• Akaike, A., Tamura, Y., Yokota, T., Shimohama, S., & Kimura, J. (1994). Nicotine-induced protection of cultured cortical neurons against _N_-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Research, 644, 181–187.
  Article CAS PubMed Google Scholar
• Akasofu, S., Kosasa, T., Kimura, M., & Kubota, A. (2003). Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen glucose deprivation. European Journal of Pharmacology, 472, 57–63.
  Article CAS PubMed Google Scholar
• Barnes, C. A., Meltzer, J., Houston, F., Orr, G., McGann, K., & Wenk, G. L. (2000). Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors. Neuroscience, 99, 17–23.
  Article CAS PubMed Google Scholar
• Collerton, D. (1986). Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience, 19, 1–28.
  Article CAS PubMed Google Scholar
• Dajas-Bailador, F., & Wonnacott, S. (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signaling. Trends in Pharmacological Sciences, 25, 317–324.
  Article CAS PubMed Google Scholar
• Darsow, T., Booker, T. K., Piña-Crespo, J. C., & Heinemann, S. F. (2005). Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors. Journal of Biological Chemistry, 280, 18311–18320.
  Article CAS PubMed Google Scholar
• Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America, 88, 6368–6371.
  Article CAS PubMed Google Scholar
• Hynd, M. R., Scott, H. L., & Dodd, P. R. (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochemistry International, 45, 583–395.
  Article CAS PubMed Google Scholar
• Kaneko, S., Maeda, T., Kume, T., Kochiyama, H., Akaike, A., Shimohama, S., et al. (1997). Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α7 neuronal receptors and neuronal CNS receptors. Brain Research, 765, 135–140.
  Article CAS PubMed Google Scholar
• Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Maeda, T., et al. (1997). Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Annals of Neurology, 42, 159–163.
  Article CAS PubMed Google Scholar
• Kihara, T., Shimohama, S., Sawada, H., Honda, H., Nakamizo, T., Shibasaki, H., et al. (2001). α7 Nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block a β-amyoid-induced neurotoxcity. Journal of Biological Chemistry, 276, 13541–13546.
  CAS PubMed Google Scholar
• Kume, T., Asai, N., Nishikawa, H., Mano, N., Terauchi, T., Taguchi, R., et al. (2002). Isolation of a diterpenoid substance with potent neuroprotective activity from fetal calf serum. Proceedings of the National Academy of Sciences of the United States of America, 99, 3288–3293.
  Article CAS PubMed Google Scholar
• Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005). Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Molecular Pharmacology, 68, 1839–1851.
  CAS PubMed Google Scholar
• Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacol. (Berl), 184, 529–534.
  Google Scholar
• Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E. X., et al. (2001). Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biological Psychiatry, 49, 279–288.
  Article CAS PubMed Google Scholar
• Marks, M. J., Pauly, J. R., Gross, S. D., Deneris, E. S., Hermans-Borgmeyer, I., Heinemann, S. F., et al. (1992). Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. Journal of Neuroscience, 12, 2765–2784.
  CAS PubMed Google Scholar
• Martinez, M., Frank, A., Diez-Tejedor, E., & Hernanz, A. (1993). Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia. Journal of Neural Transmission. Parkinson's Disease and Dementia, 6, 1–9.
  Article CAS Google Scholar
• Matsuzaki, H., Tamatani, M., Mitsuda, N., Namikawa, K., Kiyama, H., Miyake, S., et al. (1999). Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. Journal of Neurochemistry, 73, 2037–2046.
  CAS PubMed Google Scholar
• Meldrum, B., & Garthwaite, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends in Pharmacological Sciences, 11, 379–387.
  Article CAS PubMed Google Scholar
• Nordberg, A. (2006). Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Disease and Associated Disorders, 20, S12–S18.
  Article CAS PubMed Google Scholar
• Nordberg, A., Amberla, K., Shigeta, M., Lundqvist, H., Viitanen, M., Hellström-Lindahl, E., et al. (1998). Long-term tacrine treatment in three mild Alzheimer patients: Effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease and Associated Disorders, 12, 228–237.
  Article CAS PubMed Google Scholar
• Rosa, A. O., Egea, J., Gandía, L., López, M. G., & García, A. G. (2006). Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype. Journal of Molecular Neuroscience, 30, 61–62.
  Article CAS PubMed Google Scholar
• Reid, R. T., & Sabbagh, M. N. (2003). Effects of donepezil treatment on rat nicotinic acetylcholine receptor levels in vivo and in vitro. Journal of Alzheimer's Disease, 5, 429–436.
  CAS PubMed Google Scholar
• Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J. P., et al. (2005). Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron, 46, 595–607.
  Article CAS PubMed Google Scholar
• Shimohama, S., Akaike, A., & Kimura, J. (1996). Nicotine-induced protection against glutamate cytotoxicity-nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Annals of the New York Academy of Sciences, 777, 356–361.
  Article CAS PubMed Google Scholar
• Takada-Takatori, Y., Yonezawa, A., Kume, T., Katsuki, H., Kaneko, S., Sugimoto, H., et al. (2003). Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. Journal of Pharmacology and Experimental Therapeutics, 306, 772–777.
  Article CAS Google Scholar
• Takada-Takatori, Y., Kume, T., Sugimoto, M., Katsuki, H., Niidome, T., Sugimoto, H., et al. (2006a). Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity. European Journal of Pharmacology, 549, 19–26.
  Article CAS PubMed Google Scholar
• Takada-Takatori, Y., Kume, T., Sugimoto, M., Katsuki, H., Sugimoto, H., & Akaike, A. (2006b). Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacoloy, 51, 474–486.
  Article CAS Google Scholar
• Takada-Takatori, Y., Kume, T., Ohgi, Y., Izumi, Y., Niidome, T., Fujii, T., et al. (2008a). Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil. Journal of Neuroscience Research, 86, 3575–3583.
  Article CAS PubMed Google Scholar
• Takada-Takatori, Y., Kume, T., Ohgi, Y., Fujii, T., Niidome, T., Sugimoto, H., et al. (2008b). Mechanisms of alpha7-nicotinic receptor up-regulation and sensitization to donepezil induced by chronic donepezil treatment. European Journal of Pharmacology, 20, 150–156.
  Article CAS Google Scholar
• Takada-Takatori, Y., Kume, T., Izumi, Y., Ohgi, Y., Niidome, T., Fujii, T., et al. (2009). Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biological and Pharmaceutical Bulletin, 32, 318–324.
  Article CAS PubMed Google Scholar
• Tamura, Y., Sato, Y., Akaike, A., & Shiomi, H. (1992). Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against _N_-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Research, 592, 317–325.
  Article CAS PubMed Google Scholar
• Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., & Delon, M. R. (1982). Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237–1239.
  Article CAS PubMed Google Scholar
• Zhou, J., Fu, Y., & Tang, X. C. (2001). Huperzine A and donepezil protect rat phenochromocytoma cells against oxygen-glucose deprivation. Neuroscience Letters, 406, 53–56.
  Article Google Scholar

Download references